Dialysis for end stage renal disease financed through the Brazilian National Health System, 2000 to 2012

BMC Nephrology

Maria Inês Schmidt³  Fernando Saldanha Thome¹  Bruce Bartholow Duncan³  Isaías Valente Prestes³  Lenildo de Moura² 

[1] School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil;Technical Unit for Health risks, Noncommunicable Diseases and Mental Health, Pan-American Health Organization, Setor de Embaixadas Norte, Lote 19, CEP: 70.800-400 Brasília, DF, Brazil;Post-Graduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil

关键词: Dialysis;    Ethnicity;    Incidence;    Prevalence;    End-stage renal disease;   

Others  :  847143
DOI  :  10.1186/1471-2369-15-111

 received in 2014-03-10, accepted in 2014-07-03,  发布年份 2014

【 摘 要 】

Background

Chronic kidney disease has become a public health problem worldwide. Its terminal stage requires renal replacement therapy – dialysis or transplantation – for the maintenance of life, resulting in high economic and social costs. Though the number of patients with end-stage renal disease treated by dialysis in Brazil is among the highest in the world, current estimates of incidence and prevalence are imprecise. Our aim is to describe incidence and prevalence trends and the epidemiologic profile of end-stage renal disease patients receiving publically-financed dialysis in Brazil between 2000 and 2012.

Methods

We internally linked records of the High Complexity Procedure Authorization/Renal Replacement Therapy (APAC/TRS) system so as to permit analyses of incidence and prevalence of dialysis over the period 2000-2012. We characterized temporal variations in the incidence and prevalence using Joinpoint regression.

Results

Over the period, 280,667 patients received publically-financed dialysis, 57.2% of these being male. The underlying disease causes listed were hypertension (20.8%), diabetes (12.0%) and glomerulonephritis (7.7%); for 42.3%, no specific cause was recorded. Hemodialysis was the therapeutic modality in 90.1%. Over this period, prevalence increased 47%, rising 3.6% (95% CI 3.2% - 4.0%)/year. Incidence increased 20%, or 1.8% (1.1% – 2.5%)/year. Incidence increased in both sexes, in all regions of the country and particularly in older age groups.

Conclusions

Incidence and prevalence of end-stage renal disease receiving publically-financed dialysis treatment has increased notably. The linkage approach developed will permit continuous future monitoring of these indicators.

【 授权许可】

   
2014 de Moura et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009, 20:223-228.
• [2]Grassmann A, Gioberge S, Moeller S, Brown G: ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005, 20(12):2587-2593.
• [3]Couser WG, Remuzzi G, Mendis S, Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011, 80:1258-1270.
• [4]Prestes IV, de Moura L, Duncan BB, Schmidt MI: A national cohort of patients receiving publicly financed renal replacement therapy within the Brazilian Unified Health System. Lancet 2013, 381:S119.
• [5]Sesso Rde C, Lopes AA, Thome FS, Lugon JR, Watanabe Y, Santos DR: Chronic dialysis in Brazil: report of the Brazilian dialysis census, 2011. J Bras Nefrol 2012, 34(3):272-277.
• [6]de Moura L, Schmidt MI, Duncan BB, Rosa dos RS, Malta DC, Stevens A, Thomé FS: Monitoramento da doença renal crônica terminal pelo subsistema de Autorização de Procedimentos de Alta Complexidade - Apac - Brasil, 2000 a 2006. Epidemiol Serv Saúde 2009, 18:121-131.
• [7]Cusumano A, Garcia Garcia G, Gonzalez Bedat C: The Latin American Dialysis and Transplant Registry: Report 2006. Ethn Dis 2009, 19(Suppl 1):S1-S3.
• [8]Instituto Brasileiro de Geografia e Estatística – IBGE: Projeção da população do Brasil por sexo e idade para o período 2000/2060. Available in: http://www.ibge.gov.br/home/estatistica/populacao/projecao_da_populacao/2013/default.shtm webcite [Last accessed: December 12, 2013]
• [9]Statistical Research & Applications Branch, National Cancer Institute: Joinpoint regression software. Version 4.0.4. Available at: http://surveillance.cancer.gov/joinpoint/ webcite [Last accessed: December 12, 2013]
• [10]U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013. Available in: http://www.usrds.org/2013/pdf/v2_ch12_13.pdf webcite. [Last accessed: December 12, 2013.]
• [11]Cusumano AM, Gonzalez Bedat MC, García-García G, Maury Fernandez S, Lugon JR, Poblete Badal H, Elgueta Miranda S, Gómez R, Cerdas Calderón M, Almaguer López M, Moscoso Tobar J, Leiva Merino R, Sánchez Polo J, Lou Meda R, Franco Acosta B, Ayala Ferrari R, Escudero E, Saavedra López A, Mena Castro E, Milanés C, Carlini R, Duro Garcia V: Latin American Dialysis and Renal Transplant Registry: 2008 Report (data 2006). Clin Nephrol 2010, 74(Suppl 1):S3-S8.
• [12]Brasil. Associação Brasileira de Transplante de Órgãos, ABTO: Registro Brasileiro de Transplantes: Dados Numéricos da doação de órgãos e transplantes realizados por estado e instituição no período: Janeiro/Junho. 2013. 2013. Available in: http://www.abto.org.br/abtov03/Upload/file/RBT/2013/rbt2013semestre-parcial.pdf webcite. [Last accessed: December 12, 2013.].
• [13]Schaubel DE, Morrison HI, Desmeules M, Parsons DA, Fenton SS: End-stage renal disease in Canada: prevalence projections to 2005. CMAJ 1999, 160:1557-1563.
• [14]Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St PW, Guo H, Gustafson S, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, et al.: US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011, 57:A8. e1–A8,526
• [15]Cherchiglia ML, Machado EL, Szuster DAC, Andrade EIG, Acurcio FA, Caiaffa WT, Sesso R, Guerra Junior AA, de Queiroz OV, Gomes IC: Perfil epidemiológico dos pacientes em terapia renal substitutiva no Brasil, 2000-2004. Rev Saude Publica 2010, 44:639-649.
• [16]Barsoum RS: Overview: end-stage renal disease in the developing world. Artif Organs 2002, 26:737-746.
• [17]Sancho LG, Dain S: Cost-effectiveness analysis of renal replacement therapies: how should we design research on these interventions in Brazil? Cad Saude Publica 2008, 24(6):1279-1290.
• [18]Abreu PF: Doença Renal Crônica e Saúde Pública. J Bras Nefrol 2006, 28(Suppl 2):6-7.